Form 8-K - Current report:
SEC Accession No. 0001437749-18-001780
Filing Date
2018-02-06
Accepted
2018-02-06 11:55:58
Documents
3
Period of Report
2018-02-06
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K avir20180206_8k.htm 8-K 37877
2 EXHIBIT 99.1 ex_104404.htm EX-99.1 20350
3 aviragen_logo.jpg GRAPHIC 5881
  Complete submission text file 0001437749-18-001780.txt   67944
Mailing Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009
Business Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009 301-770-3099
Aviragen Therapeutics, Inc. (Filer) CIK: 0000072444 (see all company filings)

EIN.: 591212264 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-35285 | Film No.: 18576750
SIC: 2836 Biological Products, (No Diagnostic Substances)